世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
化学療法誘発性末梢神経障害治療の世界市場レポート 2023年以下を含む1) 薬剤クラス別薬物クラス別：神経保護療法；抗炎症療法；神経伝達物質ベース療法；抗酸化剤2) 治療法別：薬物療法; 療法3) 薬剤タイプ別：ブランド；ジェネリック4) 流通チャネル別：病院薬局；小売薬局；抗酸化剤病院薬局；小売薬局；オンライン薬局5) エンドユーザー別：病院；研究機関；専門クリニックカバーする：サノフィSA; ブリストル・マイヤーズ スクイブ; アボット・ラボラトリーズ; 武田薬品工業; アムジェンInc.Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Report 2023Including: 1) By Drug Class: Nerve Protective Therapy; Anti-Inflammatory Therapy; Neurotransmitter Based Therapy; Antioxidantes2) By Treatment: Medication; Therapy3) By Drug Type: Branded; Generic4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacies5) By End-User: Hospitals; Research Institutes; Specialty ClinicsCovering: Sanofi SA; Bristol Myers Squibb; Abbott Laboratories; Takeda Pharmaceutical Company; Amgen Inc. The Business Research Companyの化学療法誘発性末梢神経障害治療の世界市場レポート2023は、戦略家、マーケティング担当者、上級管理職が市場を評価するために必要な重要情報を提供します。 このレポートは、... もっと見る
サマリーThe Business Research Companyの化学療法誘発性末梢神経障害治療の世界市場レポート2023は、戦略家、マーケティング担当者、上級管理職が市場を評価するために必要な重要情報を提供します。このレポートは、力強い成長を遂げている化学療法誘発性末梢神経障害治療市場に焦点を当てています。今後10年間およびそれ以降の市場を形成するトレンドのガイドを提供します。 購入の理由 - 50以上の地域をカバーするこの市場に関する最も包括的なレポートにより、真にグローバルな視点を得ることができます。 - 市場がCOVID-19の影響をどのように受けてきたか、またウイルスの影響が和らぐにつれて市場がどのように対応しているかを理解する。 - ロシア・ウクライナ戦争が農業、エネルギー、鉱物資源供給に与える影響と、市場への直接的・間接的影響を評価する。 - 世界的な高インフレが市場成長に与える影響を測定する。 - 現地のデータと分析に基づき、地域戦略と国別戦略を策定する。 - 投資の対象となる成長セグメントを特定する。 - 予測データと市場を形成する原動力とトレンドを活用し、競合他社を凌駕する。 - 最新の市場シェアに基づいて顧客を理解する。 - 主要な競合他社に対する業績のベンチマーク - 信頼性の高い高品質のデータと分析により、社内外でのプレゼンテーションをサポートするのに適しています。 - レポートは最新データに更新され、データ抽出と分析が簡単にできるExcelデータシートとともに、ご注文から3～5営業日以内にお届けします。 - レポートの全データは、エクセルのダッシュボード形式でも納品されます。 説明 化学療法による末梢神経障害治療の最大かつ最速の成長市場はどこか？同市場は経済全体、人口動態、その他の類似市場とどのように関連しているのか？今後どのような力が市場を形成していくのか？ビジネス調査会社の化学療法誘発性末梢神経障害治療世界市場レポートがこれらすべての疑問やその他多くの疑問にお答えします。 当レポートでは、市場の特徴、規模および成長、セグメンテーション、地域別および国別内訳、競合情勢、市場シェア、動向、戦略を網羅しています。地域別に市場の過去および予測市場成長を追跡します。 調査範囲 対象市場：1） 薬剤クラス別薬物クラス別：神経保護療法；抗炎症療法；神経伝達物質ベース療法；抗酸化剤；その他の薬物クラス 2) 治療法別薬物療法；治療；その他の治療 3) 薬剤の種類別：ブランド；ジェネリック 4) 販売チャネル別病院薬局；小売薬局；オンライン薬局；その他の流通チャネル 5) エンドユーザー別：病院、研究機関、専門クリニック 言及された企業サノフィSA; ブリストル・マイヤーズ スクイブ; アボット・ラボラトリーズ; 武田薬品工業; アムジェンInc. 国オーストラリア、ブラジル、中国、フランス、ドイツ、インド、インドネシア、日本、ロシア、韓国、英国、米国、カナダ、イタリア、スペイン 地域アジア太平洋; 西ヨーロッパ; 東ヨーロッパ; 北アメリカ; 南アメリカ; 中東; アフリカ 時系列：過去5年間および過去10年間の予測。 データ市場規模と成長率の関連市場に対する比率、GDP比率、一人当たり支出、 データ区分：国別・地域別の過去データと予測データ、競合他社の市場シェア、市場セグメント。 ソーシングと参照：本レポート中のデータおよび分析は、エンドノートを使用しています。 納品形式PDF、Word、Excel データダッシュボード。 目次1. Executive Summary2. Chemotherapy Induced Peripheral Neuropathy Treatment Market Characteristics 3. Chemotherapy Induced Peripheral Neuropathy Treatment Market Trends And Strategies 4. Chemotherapy Induced Peripheral Neuropathy Treatment Market - Macro Economic Scenario 4.1. Impact Of High Inflation On Online Therapy Services Market 4.2. Ukraine-Russia War Impact On Online Therapy Services Market 4.3. COVID-19 Impact On Online Therapy Services Market 5.1. Global Chemotherapy Induced Peripheral Neuropathy Treatment Historic Market Size and Growth, 2017 - 2022, Value ($ Billion) 5.2. Global Chemotherapy Induced Peripheral Neuropathy Treatment Forecast Market Size and Growth, 2022 - 2027, 2032F, Value ($ Billion) 5.3. Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Drivers and Restraints 5.3.1. Drivers Of The Market 5.3.2. Restraints Of The Market 6. Chemotherapy Induced Peripheral Neuropathy Treatment Market Segmentation 6.1. Global Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Nerve Protective Therapy Anti-Inflammatory Therapy Neurotransmitter Based Therapy Antioxidant Other Drug Classes 6.2. Global Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Medication Therapy Other Treatments 6.3. Global Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Branded Generic 6.4. Global Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Hospital Pharmacy Retail Pharmacy Online Pharmacies Other Distribution Channels 6.5. Global Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Hospitals Research Institutes Specialty Clinics 7. Chemotherapy Induced Peripheral Neuropathy Treatment Market Regional And Country Analysis 7.1. Global Chemotherapy Induced Peripheral Neuropathy Treatment Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 7.2. Global Chemotherapy Induced Peripheral Neuropathy Treatment Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8. Asia-Pacific Chemotherapy Induced Peripheral Neuropathy Treatment Market 8.1. Asia-Pacific Chemotherapy Induced Peripheral Neuropathy Treatment Market Overview Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies 8.2. Asia-Pacific Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8.3. Asia-Pacific Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8.4. Asia-Pacific Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 9. China Chemotherapy Induced Peripheral Neuropathy Treatment Market 9.1. China Chemotherapy Induced Peripheral Neuropathy Treatment Market Overview 9.2. China Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 9.3. China Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 9.4. China Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 10. India Chemotherapy Induced Peripheral Neuropathy Treatment Market 10.1. India Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 10.2. India Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 10.3. India Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11. Japan Chemotherapy Induced Peripheral Neuropathy Treatment Market 11.1. Japan Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11.2. Japan Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11.3. Japan Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12. Australia Chemotherapy Induced Peripheral Neuropathy Treatment Market 12.1. Australia Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12.2. Australia Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12.3. Australia Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13. Indonesia Chemotherapy Induced Peripheral Neuropathy Treatment Market 13.1. Indonesia Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13.2. Indonesia Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13.3. Indonesia Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14. South Korea Chemotherapy Induced Peripheral Neuropathy Treatment Market 14.1. South Korea Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14.2. South Korea Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14.3. South Korea Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15. Western Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market 15.1. Western Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market Overview 15.2. Western Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15.3. Western Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15.4. Western Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16. UK Chemotherapy Induced Peripheral Neuropathy Treatment Market 16.1. UK Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16.2. UK Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16.3. UK Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17. Germany Chemotherapy Induced Peripheral Neuropathy Treatment Market 17.1. Germany Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17.2. Germany Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17.3. Germany Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18. France Chemotherapy Induced Peripheral Neuropathy Treatment Market 18.1. France Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18.2. France Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18.3. France Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19. Italy Chemotherapy Induced Peripheral Neuropathy Treatment Market 19.1. Italy Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19.2. Italy Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19.3. Italy Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20. Spain Chemotherapy Induced Peripheral Neuropathy Treatment Market 20.1. Spain Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20.2. Spain Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20.3. Spain Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21. Eastern Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market 21.1. Eastern Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market Overview 21.2. Eastern Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21.3. Eastern Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21.4. Eastern Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22. Russia Chemotherapy Induced Peripheral Neuropathy Treatment Market 22.1. Russia Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22.2. Russia Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22.3. Russia Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23. North America Chemotherapy Induced Peripheral Neuropathy Treatment Market 23.1. North America Chemotherapy Induced Peripheral Neuropathy Treatment Market Overview 23.2. North America Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23.3. North America Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23.4. North America Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24. USA Chemotherapy Induced Peripheral Neuropathy Treatment Market 24.1. USA Chemotherapy Induced Peripheral Neuropathy Treatment Market Overview 24.2. USA Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24.3. USA Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24.4. USA Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25. Canada Chemotherapy Induced Peripheral Neuropathy Treatment Market 25.1. Canada Chemotherapy Induced Peripheral Neuropathy Treatment Market Overview 25.2. Canada Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25.3. Canada Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25.4. Canada Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26. South America Chemotherapy Induced Peripheral Neuropathy Treatment Market 26.1. South America Chemotherapy Induced Peripheral Neuropathy Treatment Market Overview 26.2. South America Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26.3. South America Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26.4. South America Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27. Brazil Chemotherapy Induced Peripheral Neuropathy Treatment Market 27.1. Brazil Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27.2. Brazil Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27.3. Brazil Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28. Middle East Chemotherapy Induced Peripheral Neuropathy Treatment Market 28.1. Middle East Chemotherapy Induced Peripheral Neuropathy Treatment Market Overview 28.2. Middle East Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28.3. Middle East Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28.4. Middle East Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29. Africa Chemotherapy Induced Peripheral Neuropathy Treatment Market 29.1. Africa Chemotherapy Induced Peripheral Neuropathy Treatment Market Overview 29.2. Africa Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29.3. Africa Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29.4. Africa Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 30. Chemotherapy Induced Peripheral Neuropathy Treatment Market Competitive Landscape And Company Profiles 30.1. Chemotherapy Induced Peripheral Neuropathy Treatment Market Competitive Landscape 30.2. Chemotherapy Induced Peripheral Neuropathy Treatment Market Company Profiles 30.2.1. Sanofi SA 30.2.1.1. Overview 30.2.1.2. Products and Services 30.2.1.3. Strategy 30.2.1.4. Financial Performance 30.2.2. Bristol Myers Squibb 30.2.2.1. Overview 30.2.2.2. Products and Services 30.2.2.3. Strategy 30.2.2.4. Financial Performance 30.2.3. Abbott Laboratories 30.2.3.1. Overview 30.2.3.2. Products and Services 30.2.3.3. Strategy 30.2.3.4. Financial Performance 30.2.4. Takeda Pharmaceutical Company 30.2.4.1. Overview 30.2.4.2. Products and Services 30.2.4.3. Strategy 30.2.4.4. Financial Performance 30.2.5. Amgen Inc. 30.2.5.1. Overview 30.2.5.2. Products and Services 30.2.5.3. Strategy 30.2.5.4. Financial Performance 31. Chemotherapy Induced Peripheral Neuropathy Treatment Market Other Major And Innovative Companies 31.1. Asahi Kasei Pharma Corporation 31.2. Toray Industries 31.3. Vertex Pharmaceuticals Inc. 31.4. Alexion Pharmaceuticals Inc. 31.5. BioMérieux SA 31.6. Jazz Pharmaceuticals Inc. 31.7. WEX Pharmaceuticals Inc. 31.8. Quidel Corporation 31.9. Laboratorios Dr. Esteve S.A. (ESTEVE) 31.10. Genentech Inc. 31.11. MediciNova Inc. 31.12. ChromaDex Corp 31.13. WinSanTor Inc. 31.14. Solasia Pharma K.K. 31.15. NeuroMetrix Inc. 32. Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Competitive Benchmarking 33. Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Competitive Dashboard 34. Key Mergers And Acquisitions In The Chemotherapy Induced Peripheral Neuropathy Treatment Market 35. Chemotherapy Induced Peripheral Neuropathy Treatment Market Future Outlook and Potential Analysis 35.1 Chemotherapy Induced Peripheral Neuropathy Treatment Market In 2027 - Countries Offering Most New Opportunities 35.2 Chemotherapy Induced Peripheral Neuropathy Treatment Market In 2027 - Segments Offering Most New Opportunities 35.3 Chemotherapy Induced Peripheral Neuropathy Treatment Market In 2027 - Growth Strategies 35.3.1 Market Trend Based Strategies 35.3.2 Competitor Strategies 36. Appendix 36.1. Abbreviations 36.2. Currencies 36.3. Historic And Forecast Inflation Rates 36.4. Research Inquiries 36.5. The Business Research Company 36.6. Copyright And Disclaimer
SummaryChemotherapy Induced Peripheral Neuropathy Treatment Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market. Table of Contents1. Executive Summary2. Chemotherapy Induced Peripheral Neuropathy Treatment Market Characteristics 3. Chemotherapy Induced Peripheral Neuropathy Treatment Market Trends And Strategies 4. Chemotherapy Induced Peripheral Neuropathy Treatment Market - Macro Economic Scenario 4.1. Impact Of High Inflation On Online Therapy Services Market 4.2. Ukraine-Russia War Impact On Online Therapy Services Market 4.3. COVID-19 Impact On Online Therapy Services Market 5.1. Global Chemotherapy Induced Peripheral Neuropathy Treatment Historic Market Size and Growth, 2017 - 2022, Value ($ Billion) 5.2. Global Chemotherapy Induced Peripheral Neuropathy Treatment Forecast Market Size and Growth, 2022 - 2027, 2032F, Value ($ Billion) 5.3. Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Drivers and Restraints 5.3.1. Drivers Of The Market 5.3.2. Restraints Of The Market 6. Chemotherapy Induced Peripheral Neuropathy Treatment Market Segmentation 6.1. Global Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Nerve Protective Therapy Anti-Inflammatory Therapy Neurotransmitter Based Therapy Antioxidant Other Drug Classes 6.2. Global Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Medication Therapy Other Treatments 6.3. Global Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Branded Generic 6.4. Global Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Hospital Pharmacy Retail Pharmacy Online Pharmacies Other Distribution Channels 6.5. Global Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Hospitals Research Institutes Specialty Clinics 7. Chemotherapy Induced Peripheral Neuropathy Treatment Market Regional And Country Analysis 7.1. Global Chemotherapy Induced Peripheral Neuropathy Treatment Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 7.2. Global Chemotherapy Induced Peripheral Neuropathy Treatment Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8. Asia-Pacific Chemotherapy Induced Peripheral Neuropathy Treatment Market 8.1. Asia-Pacific Chemotherapy Induced Peripheral Neuropathy Treatment Market Overview Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies 8.2. Asia-Pacific Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8.3. Asia-Pacific Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8.4. Asia-Pacific Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 9. China Chemotherapy Induced Peripheral Neuropathy Treatment Market 9.1. China Chemotherapy Induced Peripheral Neuropathy Treatment Market Overview 9.2. China Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 9.3. China Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 9.4. China Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 10. India Chemotherapy Induced Peripheral Neuropathy Treatment Market 10.1. India Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 10.2. India Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 10.3. India Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11. Japan Chemotherapy Induced Peripheral Neuropathy Treatment Market 11.1. Japan Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11.2. Japan Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11.3. Japan Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12. Australia Chemotherapy Induced Peripheral Neuropathy Treatment Market 12.1. Australia Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12.2. Australia Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12.3. Australia Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13. Indonesia Chemotherapy Induced Peripheral Neuropathy Treatment Market 13.1. Indonesia Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13.2. Indonesia Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13.3. Indonesia Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14. South Korea Chemotherapy Induced Peripheral Neuropathy Treatment Market 14.1. South Korea Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14.2. South Korea Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14.3. South Korea Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15. Western Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market 15.1. Western Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market Overview 15.2. Western Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15.3. Western Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15.4. Western Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16. UK Chemotherapy Induced Peripheral Neuropathy Treatment Market 16.1. UK Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16.2. UK Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16.3. UK Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17. Germany Chemotherapy Induced Peripheral Neuropathy Treatment Market 17.1. Germany Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17.2. Germany Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17.3. Germany Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18. France Chemotherapy Induced Peripheral Neuropathy Treatment Market 18.1. France Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18.2. France Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18.3. France Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19. Italy Chemotherapy Induced Peripheral Neuropathy Treatment Market 19.1. Italy Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19.2. Italy Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19.3. Italy Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20. Spain Chemotherapy Induced Peripheral Neuropathy Treatment Market 20.1. Spain Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20.2. Spain Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20.3. Spain Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21. Eastern Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market 21.1. Eastern Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market Overview 21.2. Eastern Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21.3. Eastern Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21.4. Eastern Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22. Russia Chemotherapy Induced Peripheral Neuropathy Treatment Market 22.1. Russia Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22.2. Russia Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22.3. Russia Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23. North America Chemotherapy Induced Peripheral Neuropathy Treatment Market 23.1. North America Chemotherapy Induced Peripheral Neuropathy Treatment Market Overview 23.2. North America Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23.3. North America Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23.4. North America Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24. USA Chemotherapy Induced Peripheral Neuropathy Treatment Market 24.1. USA Chemotherapy Induced Peripheral Neuropathy Treatment Market Overview 24.2. USA Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24.3. USA Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24.4. USA Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25. Canada Chemotherapy Induced Peripheral Neuropathy Treatment Market 25.1. Canada Chemotherapy Induced Peripheral Neuropathy Treatment Market Overview 25.2. Canada Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25.3. Canada Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25.4. Canada Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26. South America Chemotherapy Induced Peripheral Neuropathy Treatment Market 26.1. South America Chemotherapy Induced Peripheral Neuropathy Treatment Market Overview 26.2. South America Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26.3. South America Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26.4. South America Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27. Brazil Chemotherapy Induced Peripheral Neuropathy Treatment Market 27.1. Brazil Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27.2. Brazil Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27.3. Brazil Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28. Middle East Chemotherapy Induced Peripheral Neuropathy Treatment Market 28.1. Middle East Chemotherapy Induced Peripheral Neuropathy Treatment Market Overview 28.2. Middle East Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28.3. Middle East Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28.4. Middle East Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29. Africa Chemotherapy Induced Peripheral Neuropathy Treatment Market 29.1. Africa Chemotherapy Induced Peripheral Neuropathy Treatment Market Overview 29.2. Africa Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29.3. Africa Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29.4. Africa Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 30. Chemotherapy Induced Peripheral Neuropathy Treatment Market Competitive Landscape And Company Profiles 30.1. Chemotherapy Induced Peripheral Neuropathy Treatment Market Competitive Landscape 30.2. Chemotherapy Induced Peripheral Neuropathy Treatment Market Company Profiles 30.2.1. Sanofi SA 30.2.1.1. Overview 30.2.1.2. Products and Services 30.2.1.3. Strategy 30.2.1.4. Financial Performance 30.2.2. Bristol Myers Squibb 30.2.2.1. Overview 30.2.2.2. Products and Services 30.2.2.3. Strategy 30.2.2.4. Financial Performance 30.2.3. Abbott Laboratories 30.2.3.1. Overview 30.2.3.2. Products and Services 30.2.3.3. Strategy 30.2.3.4. Financial Performance 30.2.4. Takeda Pharmaceutical Company 30.2.4.1. Overview 30.2.4.2. Products and Services 30.2.4.3. Strategy 30.2.4.4. Financial Performance 30.2.5. Amgen Inc. 30.2.5.1. Overview 30.2.5.2. Products and Services 30.2.5.3. Strategy 30.2.5.4. Financial Performance 31. Chemotherapy Induced Peripheral Neuropathy Treatment Market Other Major And Innovative Companies 31.1. Asahi Kasei Pharma Corporation 31.2. Toray Industries 31.3. Vertex Pharmaceuticals Inc. 31.4. Alexion Pharmaceuticals Inc. 31.5. BioMérieux SA 31.6. Jazz Pharmaceuticals Inc. 31.7. WEX Pharmaceuticals Inc. 31.8. Quidel Corporation 31.9. Laboratorios Dr. Esteve S.A. (ESTEVE) 31.10. Genentech Inc. 31.11. MediciNova Inc. 31.12. ChromaDex Corp 31.13. WinSanTor Inc. 31.14. Solasia Pharma K.K. 31.15. NeuroMetrix Inc. 32. Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Competitive Benchmarking 33. Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Competitive Dashboard 34. Key Mergers And Acquisitions In The Chemotherapy Induced Peripheral Neuropathy Treatment Market 35. Chemotherapy Induced Peripheral Neuropathy Treatment Market Future Outlook and Potential Analysis 35.1 Chemotherapy Induced Peripheral Neuropathy Treatment Market In 2027 - Countries Offering Most New Opportunities 35.2 Chemotherapy Induced Peripheral Neuropathy Treatment Market In 2027 - Segments Offering Most New Opportunities 35.3 Chemotherapy Induced Peripheral Neuropathy Treatment Market In 2027 - Growth Strategies 35.3.1 Market Trend Based Strategies 35.3.2 Competitor Strategies 36. Appendix 36.1. Abbreviations 36.2. Currencies 36.3. Historic And Forecast Inflation Rates 36.4. Research Inquiries 36.5. The Business Research Company 36.6. Copyright And Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療）の最新刊レポート
The Business Research Company (TBRC)社の医療サービス分野での最新刊レポート
本レポートと同じKEY WORD（chemotherapy）の最新刊レポート
よくあるご質問The Business Research Company (TBRC)社はどのような調査会社ですか?The Business Research Company (TBRC)はインドを主要拠点に世界の多様な市場を調査・予測し、調査レポートを積極的に出版しています。調査対象には技術、ライフサイエンス、重... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
